Combined ipratropium and beta2--adrenergic receptor agonist in acute asthma.
Herner
S J
SJ
Fort Collins Family Medicine Residency Program, CO 80524-3998, USA.
Seaton
T L
TL
Mertens
M K
MK
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009241:Ipratropium / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D009241:Ipratropium